Combining mucosal microbiome and host multi-omics data shows prognostic potential in paediatric ulcerative colitis
Abstract Current first-line treatments of paediatric ulcerative colitis (UC) maintain a 6-month remission in only half of the patients. Relapse prediction at diagnosis could enable earlier introduction of immunosuppressants. We collected intestinal biopsies from 56 treatment-naïve children, combinin...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Nature Portfolio
2025-08-01
|
| Seri Bilgileri: | Nature Communications |
| Online Erişim: | https://doi.org/10.1038/s41467-025-62533-z |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|
